Skip to content
DraconiticResearch
Search Sources API
201,683 studies31 sourcesUpdated 27 min ago
Peer-reviewedCC BYFrontiers in endocrinology

Diabetes in Cushing’s disease: age, hypercortisolism, central adiposity, and β-cell stress as determinants of glycaemia

4 affiliations
  1. 1Department of Internal Medicine, Endocrinology and Diabetes, Medical University of Warsaw , ,
  2. 2Department of Diabetology, Institute of Mother and Child , ,
  3. 3Department of Epidemiology and Biostatistics, Institute of Mother and Child , ,
  4. 4Department of Neurosurgery, Military Institute of Medicine, National Research Institute , ,

Abstract

Objective: Diabetes is a frequent complication of Cushing’s disease, but metabolic differences between normal glucose tolerance, prediabetes, and diabetes remain incompletely characterised. We aimed to characterise glucose metabolism across these groups, assess abnormalities in patients with normal glucose tolerance, and identify clinical, hormonal, and body-composition factors associated with glycaemia.

Design: Cross-sectional analysis of a prospective cohort with matched healthy controls.

Material and methods: The study included 50 patients with Cushing’s disease and 52 age- and sex-matched healthy controls who underwent detailed metabolic phenotyping, including multi-timepoint oral glucose tolerance testing with assessment of insulin sensitivity and β-cell compensatory function, and body composition analysis by dual-energy X-ray absorptiometry. Forward stepwise linear regression was performed separately in each group to identify variables independently associated with HbA1c.

Results: Glucose metabolism disturbances affected 68% of patients with Cushing’s disease, including prediabetes in 42% and diabetes in 26%, with most diabetes cases previously undiagnosed. Even patients with normal glucose tolerance showed lower insulin sensitivity and enhanced β-cell secretory activity compared with healthy controls. Prediabetes was characterised mainly by lower insulin sensitivity with preserved β-cell compensation, whereas diabetes was associated with a reduced insulin-to-glucose AUC ratio without significantly lower insulin sensitivity than in prediabetes. In Cushing’s disease, age, morning cortisol, waist-to-hip ratio, and proinsulin were independently associated with HbA1c, explaining 59.5% of its variance; in controls, only age and BMI were associated with HbA1c. BMI was not significantly correlated with HbA1c in Cushing’s disease, whereas trunk fat percentage was positively associated with HbA1c.

Conclusions: In Cushing’s disease, reduced insulin sensitivity with preserved β-cell compensation is detectable even in patients with normal glucose tolerance, whereas overt diabetes is characterised by impaired β-cell compensation without significantly lower insulin sensitivity than in prediabetes. Age, morning cortisol, waist-to-hip ratio, and proinsulin are independently associated with HbA1c. Central fat distribution may be more closely related to glycaemia than BMI.

Related

  1. Association of life course type 2 diabetes duration with adverse cardiac structure independent of current glycaemia in the British MRC National Survey of Health and Development Birth Cohort
    Lamia Al Saikhan, Nishi Chaturvedi, Arjun K Ghosh +2
    BMJ OpenPeer-reviewedCC BY 4.0Full textCardiovascular medicineCrossref
  2. Case Report: A case study on bilateral macronodular adrenocortical disease: ACTH-independent hypercortisolism with refractory diabetes and hypertension
    Yujia Qiu, Pengtao Song, Jianping Yao +2
    Frontiers in EndocrinologyPeer-reviewedCC BY 4.0Full textSurgery & anaesthesiaCrossref
  3. Changes in body composition and adiposity following an eight-week health-promotion intervention among adolescents and young adults with type 1 diabetes in Wakiso, Uganda: A controlled before-and-after study
    J. Nsamba, S. Garelnabi, C. Mwanje +4
    medRxivPreprintCC BYFull textEndocrinology & metabolismmedRxiv
  4. Social Determinants of Health and Behavioral Risk Factors in the Tuberculosis-Type 2 Diabetes Syndemic: A Narrative Review
    Archana Banda, Kim Pedrigal, Savannah Jayne +1
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Trends, patterns, and determinants of dietary supplement use in patients with Type 2 Diabetes Melitus
    Zahra Bahadoran, Zahra Nozari, Fereidoun Azizi
    Journal of Diabetes and Metabolic DisordersPeer-reviewedLicence not statedFull textEpidemiology & public healthPMC
BibTeX
@article{witek2026diabetes,
  title = {{Diabetes in Cushing’s disease: age, hypercortisolism, central adiposity, and β-cell stress as determinants of glycaemia}},
  author = {Przemysław Witek and Jakub Kwiatkowski and Joanna Witek and Katarzyna Szamotulska and Grzegorz Zieliński},
  journal = {Frontiers in endocrinology},
  year = {2026},
  month = sep,
  doi = {10.3389/fendo.2026.1941836},
  url = {https://europepmc.org/article/PMC/PMC13662288},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Diabetes in Cushing’s disease: age, hypercortisolism, central adiposity, and β-cell stress as determinants of glycaemia
AU  - Przemysław Witek
AU  - Jakub Kwiatkowski
AU  - Joanna Witek
AU  - Katarzyna Szamotulska
AU  - Grzegorz Zieliński
PY  - 2026
DA  - 2026/09/30
JO  - Frontiers in endocrinology
DO  - 10.3389/fendo.2026.1941836
UR  - https://europepmc.org/article/PMC/PMC13662288
AB  - Objective: Diabetes is a frequent complication of Cushing’s disease, but metabolic differences between normal glucose tolerance, prediabetes, and diabetes remain incompletely characterised. We aimed to characterise glucose metabolism across these groups, assess abnormalities in patients with normal glucose tolerance, and identify clinical, hormonal, and body-composition factors associated with glycaemia.  Design: Cross-sectional analysis of a prospective cohort with matched healthy controls.  Material and methods: The study included 50 patients with Cushing’s disease and 52 age- and sex-matched healthy controls who underwent detailed metabolic phenotyping, including multi-timepoint oral glucose tolerance testing with assessment of insulin sensitivity and β-cell compensatory function, and body composition analysis by dual-energy X-ray absorptiometry. Forward stepwise linear regression was performed separately in each group to identify variables independently associated with HbA1c.  Results: Glucose metabolism disturbances affected 68% of patients with Cushing’s disease, including prediabetes in 42% and diabetes in 26%, with most diabetes cases previously undiagnosed. Even patients with normal glucose tolerance showed lower insulin sensitivity and enhanced β-cell secretory activity compared with healthy controls. Prediabetes was characterised mainly by lower insulin sensitivity with preserved β-cell compensation, whereas diabetes was associated with a reduced insulin-to-glucose AUC ratio without significantly lower insulin sensitivity than in prediabetes. In Cushing’s disease, age, morning cortisol, waist-to-hip ratio, and proinsulin were independently associated with HbA1c, explaining 59.5% of its variance; in controls, only age and BMI were associated with HbA1c. BMI was not significantly correlated with HbA1c in Cushing’s disease, whereas trunk fat percentage was positively associated with HbA1c.  Conclusions: In Cushing’s disease, reduced insulin sensitivity with preserved β-cell compensation is detectable even in patients with normal glucose tolerance, whereas overt diabetes is characterised by impaired β-cell compensation without significantly lower insulin sensitivity than in prediabetes. Age, morning cortisol, waist-to-hip ratio, and proinsulin are independently associated with HbA1c. Central fat distribution may be more closely related to glycaemia than BMI.
SN  - 1664-2392
ER  -